Abstract
These 4 hypothetical cases highlight some of the new features in the 2018 American Heart Association/American College of Cardiology multisociety cholesterol management guidelines. Topics include management issues in a secondary prevention patient judged to be at very high risk of another event, a patient with familial hypercholesterolemia with a low-density lipoprotein cholesterol level of 190 mg/dL or greater (to convert to millimoles per liter, multiply by 0.0259), a primary prevention patient with intermediate (7.5%-19.9%) 10-year atherosclerotic cardiovascular risk, and a patient who has statin-associated adverse effects. A multiple-choice format is used to engage clinicians in selecting the best choice based on guidance from the new 2018 cholesterol management guidelines..
Original language | English (US) |
---|---|
Pages (from-to) | 473-477 |
Number of pages | 5 |
Journal | JAMA cardiology |
Volume | 4 |
Issue number | 5 |
DOIs | |
State | Published - May 2019 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine